Martin Moen

Communicating economic status of industry with regard to policies that support ongoing competitiveness of BC's forest industry. Impacts of US tariffs on Canadian lumber exports - Federal backstop program in 2025. Softwood Lumber support program. Softwood Lumber Agreement between the Government of Canada and the Government of the United Sates of America with regards to negotiations impacting members and renegotiating of Canada/US Mexico (CUSMA) Agreement. Discussions on trade diversification. Agreements or collaboration between Canada and the US on Softwood Lumber.

Discussions concerning policies, that relate to Canadian defense spending, including opportunities to Canada's automotive sector Auto Innovation Fund, Strategic Innovation Fund, Strategic Response Fund, and R&D/Innovation Funds: Financial assistance and funding with ongoing manufacturing investments in Canada for vehicle and engine manufacturing facilities and R&D centres. Discussions about federal efforts to address automotive theft as they relate to vehicle tracking, law enforcement collaboration, and regulatory measures. Discussions about Transport Canada’s connected vehicle security policies as they relate to industry standards, cybersecurity risks and regulatory compliance Review of Canada's Bank Act and financial regulations in Canada U.S. policies regarding the auto sector as it relates to Canadian automotive, steel, aluminum and critical mineral exports and imports. U.S. policies regarding tariffs as it relates to Canadian automotive, steel, aluminum and critical mineral exports. U.S. policies regarding trade as it relates to Canadian automotive, steel, aluminum and critical mineral exports. Provide an overview of Canada's integrated auto sector and Canada's role in the global auto sector Promote investments and improvements to new and existing trade infrastructure to support the automotive manufacturing supply chain. Ensure an automotive strategy provides for a competitive environment that encourages maintenance of current and new automotive investment. Discussion concerning policies that relate to import and export of vehicles and parts, including impact on Canada's automotive sector and national security. Discussions concerning investments in Canada as it relates to automotive and automotive parts manufacturing, EV battery and EV battery supply chain manufacturing, critical minerals, including incentive support and taxation. Budget recommendations related to attracting investment to Canada, business competitiveness, taxation, grants and incentives, and any other policies or regulations related to automotive sector, advanced manufacturing and R&D Discussions regarding transportation, vehicle electrification and reducing greenhouse gas emissions, including the government's light-duty Zero Emission Vehicle (ZEV) sales mandate regulation, ZEV charging and refueling infrastructure development, and consumer issues. Discussions related to the broad range of electrified vehicles and multi-energy technologies Discussions regarding consultations, policies and regulations related to technology and IT Communications Discussions regarding consultation, outreach, policies and opportunities related to investment, development, export/import of critical minerals Transportation system policies and disruptions, CBSA Assessment & Revenue Management (CARM); Beyond the Border; Trusted Trader; Customs Self Assessment (CSA); support border policies and administration by CBSA supports and enhances trans-border shipments of goods, cross-border movement of workers who perform essential services, and security. Trade agreement negotiation and policies/regulations/tariffs related to import/exports to support the Canadian automotive sector Bilateral and plurolateral trade agreements comprehend the North American integration of the Automotive industry USMCA: Participation in consultation group in the renegotiation of the United States, Mexico, Canada agreement, administered by Global Affairs Canada. Technology Partnerships Canada (PSIP Project 494063 - Government Support to Renew Oakville Assembly Complex) Section 232 - Participating in discussions to highlight impact of steel and aluminum tariffs on Canadian automotive industry Pan Canadian Framework on Clean Growth and Climate Change: Participation in working groups (ZEV strategy) administered by various ministries including ISED, Natural Resources Canada and Transport Canada. Other trade agreements (ie: Mercosur, China) - Participating in working groups to promote fair trade agreement supportin

Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations. Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time to reimbursement and streamline federal/provincial listing processes. Discussion focused on sharing perspectives on priorities and resourcing. In particular, a shared observation of an increase in submission reviews exceeding established timeframes and increasing challenges with securing pre-filing meetings were discussed Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility". Merck is seeking to ensure Canada's continued compliance with its obligations under TRIPs relevant to the biopharmaceutical industry within all domestic legislation in addition to ongoing and future trade negotiations. Relevant domestic legislation includes the Food and Drugs Act, the Patent Act, and related regulations and guidance documents. Beyond TRIPs, Merck is seeking enhancements to increase the stability and global competitiveness of Canada’s intellectual Property legislation, regulations and policies relevant to the biopharmaceutical industry. Such enhancements may result from domestic policy in addition to bilateral and multilateral trade negotiations (e.g. Comprehensive Economic and Trade Agreement (CETA) and the Trans-Pacific Partnership (TPP). World Health Organization issues concerning pharmaceuticals as it relates to Counterfeits, Access to Medicines, and the Intergovernment Working Group (IGWG). US - Canada Regulatory Cooperation Council (RCC) as it relates to the regulation of biopharmaceutical products. The government's Science and Technology strategy as it relates to the biopharmaceutical industry. Subsequent Entry Biologics (SEBs) as it relates to Regulations, Policies, or Guidelines being developed by Health Canada, specifically the Draft Guidance Document on SEBs, the Notices of Changes to Health Canada's Guidance Documents on Data Protection and Patented Medicines Regulations (Notice of Compliance) Regulations. Smart Regulations as it relates to the biopharmaceutical industry. Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits. Policies and programs as it relates to vaccine approval, procurement and public awareness of immunization. Plan design and reimbursement policies for drug plans administered by Federal Government including NIHB and Corrections Services. Pharmaceutical pricing policy issues arising from the jurisdiction of the Patended Medicines Prices Review Board (PMPRB) and R&D reporting. Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products. Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive. Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products. Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products. Partnership opportunities as it relates to Canada's policy and programs to improve health in the developing world, such as Maternal and Child Health. New Substances Notification Regulations as it relates to the biopharmaceutical industry. National Pharmaceutical Strategy as it relates to the federal government's involvement in federal/provincial access to medicines framework. Income Tax Act as it relates to biopharmaceutical products. Health Canada's Legislative and Regulatory Modernization (LRM) as it relates to the review, approval, transparency and compliance activities of biopharm

Représentations afin de faire valoir les intérêts commerciaux de l'industrie canadienne de la production primaire d'aluminium dans le cadre des relations commerciales entre le Canada et les États-Unis, plus précisément afin que le gouvernement canadien prenne position auprès des autorités gouvernementales américaines afin que les sociétés canadiennes de production d’aluminium puissent maintenir l’exportation de leur production vers les États-Unis, incluant notamment en ce qui concerne la situation tarifaire. Représentations en appui au Conseil du Patronat du Québec, afin d'obtenir du gouvernement canadien un appui financier, en dehors du cadre d'un programme, afin de financer une initiative en ligne visant à diffuser une plateforme Web faisant la promotion des retombées positives d’accords commerciaux avec les États-Unis et le Mexique. Les sommes pourraient servir à payer des salaires pour réaliser le projet. Les programmes visés, la forme du soutien financier et les montants sont inconnus à ce jour. Participation à une table de concertation sectorielle d'Environnement et Changement climatique Canada au sujet du nouveau cadre réglementaire entourant les émissions de gaz à effet de serre à être introduit. Les représentations visent, aux fins de l’adoption des nouveaux règlements, l’adoption de critères spécifiques au secteur de l’aluminium pour les niveaux d’émissions et les activités visées. Les représentations visent également les mécanismes d’application et de suivi de la conformité pour ces règlements. Participation à une table de concertation sectorielle d'Environnement et Changement climatique Canada au sujet de l’adoption de nouvelles normes nationales de qualité de l’air ambiant à être introduites. Les représentations visent à ce que ces nouvelles normes tiennent compte des particularités du secteur de l’aluminium, incluant notamment celles ayant trait aux émissions de dioxyde de soufre. Participation à un comité de travail créé par Environnement et Changement climatique Canada concernant le nouveau système de gestion de la qualité de l'air à être introduit. Les représentations visent, aux fins des nouvelles ententes de performance environnementales, l'élaboration de normes quantitatives et qualitatives propres au secteur de l'aluminium, ainsi que l'élaboration d'un code de bonnes pratiques pour les particules fines qui tient comptes des particularités du secteur de l'aluminium.

Environment - We ask the government to support the continued introduction and adoption of clean energy and green technology on farms by providing existing and future sustainability programs with sufficient and ongoing funding. BC Dairy is seeking to work with government to address the mounting challenges faced by dairy farmers due to soaring production costs. Rising expenses for feed, labour, and other inputs continue to impact dairy farm business sustainability. BC Dairy seeks to engage with government to ensure the sustainability of this vital sector's ability to feed communities. We ask that Canada’s suite of BRM programs be reviewed and updated with a view to modernizing these programs to increase accessibility and provide optimum support to farmers and producers. International Trade - The dairy industry supports maintaining Canada's supply managed agricultural system. One of the main pillars for the success of supply management (on which the dairy industry in Canada is based) is import control. We have an interest in increasing resources for CFIA and CBSA to ensure compliance for imported products. When market concessions occur in trade agreements, including the Canada-United States-Mexico Agreement (CUSMA), we seek federal government mitigation for impacts on dairy farmers. We also seek the maximization of allowable permanent TRQs allocated to Canadian dairy processors. We ask that no domestic dairy market concessions are made in future trade agreements. Health - As per Canada's food guide, we encourage the public to consume milk to meet the daily dairy requirements of important vitamins and minerals. We seek for the inclusion of the latest scientific evidence about the nutritional value of dairy products within Canada's Healthy Eating Strategy on an on-going basis. Consumer Issues - The perceived quality and safety of Canadian dairy products versus that of imported goods is of paramount concern to the dairy industry. To this end, we have an interest in ensuring the integrity of the Product of Canada and Made in Canada logos by maintaining the current Canadian thresholds and continuing to transparently identify imported content on dairy products. We support the introduction of a Grocery Code of Conduct to strengthen domestic food security for consumers. We ask that parliamentarians commit to protecting the current Standards of Identity for Dairy Products, which limit the use of dairy terminology and imagery to animal agriculture. In addition, we ask that these regulations continue to be enforced.

Environment - BC Dairy seeks to engage the government in response to climate events that have impacted the agriculture sector over the past several years and coordinate Emergency Planning, Management & Response moving forward. International Trade- We have an interest in increasing resources for CFIA and CBSA to ensure compliance for imported products. One of the main pillars for the success of supply management (on which the dairy industry in Canada is based) is import control. International Trade – BC Dairy seeks the maximization of allowable permanent Tariff Rate Quotas (TRQ) allocated to Canadian dairy processors. International Trade - The dairy industry supports maintaining Canada's supply managed agricultural system. When market concessions occur in trade agreements, including the Canada-United States-Mexico Agreement (CUSMA), we seek federal government mitigation for impacts on dairy farmers. We ask that no domestic dairy market concessions are made in future trade agreements. Environment - We ask the government to support the continued introduction and adoption of clean energy and green technology on farms by providing existing and future sustainability programs with sufficient and ongoing funding. Consumer Issues - We ask that parliamentarians commit to protecting the current Standards of Identity for Dairy Products, which limit the use of dairy terminology and imagery to animal agriculture. In addition, we ask that these regulations continue to be enforced. Consumer Issues - The perceived quality and safety of Canadian dairy products versus that of imported goods is of paramount concern to the dairy industry. To this end, we have an interest in ensuring the integrity of the Product of Canada and Made in Canada logos by maintaining the current Canadian thresholds and continuing to transparently identify imported content on dairy products. Agriculture - We ask that Canada’s suite of Business risk management (BRM) programs be reviewed and updated with a view to modernizing these programs to increase accessibility and provide optimum support to farmers and producers. Agriculture - BC Dairy is seeking to work with government to address the mounting challenges faced by dairy farmers to reduce production costs. Rising expenses for feed, labour, and other inputs continue to impact dairy farm business sustainability. Health - As per Canada's food guide, we encourage the public to consume milk to meet the daily dairy requirements of important vitamins and minerals. We seek for the inclusion of the latest scientific evidence about the nutritional value of dairy products within Canada's Healthy Eating Strategy on an on-going basis.

Border/port security policy, capacity, and federal-provincial coordination to combat auto theft. Ensure connected vehicle security and national security activities meet the intended objectives in a manner that is efficient with fully aligned outcomes with the U.S. Competitive industrial policies and supports such as the Strategic Innovation Fund. Revisions to the Workplace Hazardous Materials information system and inclusion of globally Harmonized System clarification and labelling of chemicals must recognize the integration production facilities and processes in Canada and the U.S. Regulatory requirements for conventional alternative and renewable fuels and associated fuel quality standards to support vehicle emission control technology and vehicle performance. Promote transportation infrastructure and policies to support testing and deployment of evolving vehicle technologies such as connected vehicles and automated vehicles aligned across Canada and with the U.S.; ensure efficient cross-border movement of vehicles for testing. Promote trade infrastructure to support the automotive manufacturing supply chain. Promote enhancements to highway infrastructure, including that for connected vehicle and automated vehicle technologies; transportation and border infrastructure that support the efficient movement of goods in a just-in-time supply chain environment. Ensure efficiencies in reporting fuel consumption data for the annual fuel consumption guide; ensure website and fuel economy labels are consistent with those in the U.S. Trade agreement negotiation and implementation that maximizes commercial benefits and export opportunities. Federal privacy, AI, cybersecurity-related legislation and regulation; Canadian Anti-spam legislation and regulation; Competition Act amendments; related to the development of new advancements in vehicle technology and in-vehicle communication. Ensure regulatory requirements for vehicle safety and supporting programs and policies meet the intended safety objectives and are aligned and synchronized with the U.S. Ensure the requirements of the Chemical Management plan are developed and applied in a manner that achieves the government's objectives and does not disrupt vehicle manufacturing operations and vehicles and new vehicle battery operations. Ensure the implementation of the new Canadian Environmental Protection Act is applied in a manner that does not disrupt manufacturing operations, vehicles, and vehicle battery operations. Ensure the alignment of Canada and U.S. vehicle emission and greenhouse gas standards, for light duty (2025 and beyond), and heavy duty vehicles (2019 and beyond) under the Canadian Environmental Protection Act. Ensure that federal ZEV policies support consumer uptake and demand, and comprehend the integrated nature of the auto industry and the need for alignment with U.S. federal ZEV policies and programs. Ensure that the proposed Clean Electricity Regulations do not impede the uptake and adoption of ZEVs and building out ZEV charging infrastructure. Ensure low EI rates are maintained and do not unreasonable raise the cost of doing business in Canada, or negatively impact competitiveness for new investment Ensure any further review of the Canadian Environmental Protection Act is applied in a manner that achieves the governments objectives and does not disrupt manufacturing operations and vehicles. Ensure an automotive strategy provides for a competitive environment that encourages maintenance of current and new automotive investment. Ensure alignment of Canada U.S. harmonized Tier 3 and beyond vehicle criteria air emission standards and supporting fuel quality requirements Employment and Training maintaining a strong apprenticeships system across Canada for a skilled workforce. Ensure there is an efficient temporary international worker process to allow for specialized expertise that is required for company-specific tasks. Data privacy framework that comprehends the develop

Health Canada's consultation and next steps around regulation of foods derived from somatic cell nuclear transfer clones. Agriculture and dairy farming (Farm Management and Technology and Social/Policy Challenges) International trade negotiations and ensuring mitigation measures for existing/future trade agreements. WTO (World Trade Organization) Negotiations on Agriculture as it relates to supply management. Use of Veterinary Natural Health Products in dairy livestock production - Veterinary Drugs Directorate of Health Canada. Trans fats, Saturated fats, Sodium and Sugar as it relates to dairy products, Food Guide recommendations and nutritional labelling. Traceability Under "Agricultural Partnership", the establishment of regulations for traceability. Collaborating with provincial and federal governments in the determination of private and public interests and in discussions with Ministers re government/industry share of costs. Research Under "Canadian Agricultural Partnership", the federal Minister of Agriculture and Agri-food announced a research cluster, in cooperation with Dairy Farmers of Canada, worth $12M. Quality Milk Program - Implementation and administration of the Quality Milk Program under the Canadian On-Farm Food Safety Program of AAFC. Product of Canada consultations Dairy Farmers of Canada participated in federal government consultations on regulations pertaining to "Product of Canada". proAction - implementation and administration of the proAction program. Ingredients Industry stakeholders discussion on domestic ingredient strategy, pricing of components, marketing of ingredients. Involves discussions with the Canadian Dairy Commission. Implementation of Special Agricultural Safeguard for supply-managed products, dairy products in particular. Implementation of new tariff rate quotas for milk protein isolates as per GATT Article XXVIII, Amendment to Customs Tariff (tariff line 3504). Work with Finance Canada, AAFC and DFAIT on implementation and allocation of said TRQ. Implementation of a Grocers Code of Conduct. Guide for Food labelling and Advertising in respect of all dairy products and use of dairy terminology (modifiers, highlighted ingredients). Growing Forward. This is a federal-provincial agreement with oversight for many of our issues (Business Risk Management, Research, etc.) Food and Drug Act and its accompanying regulations as they apply to all dairy product compositional standards, in particular those on cheese and yogourt. Food and Drug Act and its accompanying regulations as it applies to the labelling and advertising of dairy products Federal framework and action plan on antimicrobial us and antimicrobial resistance. Explicit and implied Health Claims related to dairy and non-dairy products Ensure the appropriate allocation of the Tariff Rate Quotas under the Comprehensive Review of the Allocation and Administration of Tariff Rate Quotas for Dairy, Poultry and Egg Products. Discretionary Food Fortification policy of Health Canada. DFC has particular interest in the discretionary food fortification of non-nutritious foods and vitamin fortification of dairy products. Discretionary Food Fortification Governed by Food and Drug Act and the Agricultural Products Marketing Act. Development of the Code of Practice for the Care and handling of Dairy Cattle in cooperation with CFIA's activities in OIE (Organisation mondiale de la Santé Animale). Contribute to a Vision Exercise on the future of dairy with AAFC. Consultations on supplemented foods. Consultation on Vitamin D fortification. Climate Change / Environment Farm practices for greenhouse gas mitigation; documenting programs that exist provincially and federally that are available to dairy producers; promoting best management practices. Canadian Agricultural Products Act with respect to standards for ice cream and yogurt. Canada-EU Trade Agreement, CUSMA, CPTTP and Canada-UK. The components within these agreements that we are interested in are ag

Agriculture - to defend and promote the supply management system in Canada. Agriculture and International Trade - Promote and defend Canada's supply management system as it relates to the World Trade Organization and Canada-European Trade Agreement negotiations, as well as other bilateral and multilateral negotiations.

Advocating for the publication of educational materials for farmers in relation to the requirements of the Feed Regulations. Advocating to improve the regulatory burden of the feed regulations on farmers. Advocating for a new Canadian Community Health Survey - Nutrition. Advocating that government mandate the application of a rural-agricultural and economic lens to the policy development process for any policy with implications for farmers and rural Canada. Discussing Health Canada's next steps around the regulation of foods derived from somatic cell nuclear transfer clones and their offspring, and any implications for dairy farmers. Advocating for a health claim for yogurt and type II diabetes. Advocating for the adoption of the Digestible Indispensible Amino Acid Score (DIAAS) as Canada's official protein quality assessment methodology. Advocating for the protection of dairy standards of identity and compositional standards, and against the misuse of standardized dairy terms by non-dairy or lab-made products. Advocating for improved Canadian access to a wide range of critically needed veterinary healthcare tools to help improve animal welfare and reduce antimicrobial resistance. Advocating for increased federal livestock traceability requirements. Discussing dairy farmers' role in supporting the federal framework and action plan on antimicrobial use and antimicrobial resistance. Advocating for support to help farmers adjust to recent updates to the farm building code and freedom of movement requirements under the revised Code of Practice for the Care and Handling of Dairy Cattle. Collaborating with officials on the prevention, preparedness, response, and recovery relating to animal health emergencies, such as disease events or natural disasters. Advocating that the government maintain funding for programs under the next Agricultural Policy Framework (e.g. programs that support on-farm sustainability and best management practices, research, disaster relief, outbreak mitigation, business risk management, etc). Advocating for exemptions from duplicative farm-level reporting requirements under Phase II of the Federal Plastics Registry. Advocating that the federal government maintain funding where possible and ensure continuity of dairy research and that no negative impacts occur to dairy research as a result of recent funding cuts. Advocating on the importance of maintaining programs and funding that support on-farm best management practices as we work towards our mutual sustainability goals. Advocating that the government take care to ensure no direct/indirect impacts to supply management or the functioning of the system occur as a result of any changes to facilitate interprovincial trade. Advocating that the government ensure the appropriate allocation of Tariff Rate Quotas under the Comprehensive Review of the Allocation and Administration of Tariff Rate Quotas for Dairy, Poultry and Egg Products. Advocating that no concessions impacting dairy or supply management be granted in the context of any negotiations with ASEAN. Advocating that no concessions impacting dairy or supply management be granted in the context of any negotiations with the United Kingdom. Advocating that no concessions impacting dairy or supply management be granted in the context of any negotiations with Mercosur. Advocating that no concessions impacting dairy or supply management be granted in the context of any negotiations with the U.S. Advocating that no concessions impacting dairy or supply management be granted in the context of any negotiations at the WTO. Advocating for increased resources for CBSA and CFIA border enforcement of dairy regulations. This includes ensuring rigorous trade compliance of dairy imports to prevent circumvention of tariff-rate quotas (TRQs) and upholding domestic standards for all imported dairy products.

Canada's Drug Agency policies as it relates to reimbursement recommendation decision-making process and framework Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry. Federal policies that relate to possible models of pharmacare Federal Buy Canadian Procurement Policy as it relates to government drug procurement practices and the implications for the biopharmaceutical industry Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations National Strategy for Drugs for Rare Diseases World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the biopharmaceutical industry World Health Organization (WHO) issues concerning the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Income Tax Act as it relates to biopharmaceutical products Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade agreements as they relate to the biopharmaceutical industry Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry

Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB). Free trade agreements as they relate to the biopharmaceutical industry. Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations. Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes. Advocacy related to the new Buy Canada policy and the implications of including goods and services related to healthcare delivery, medical treatment, in particular drugs, vaccines and biologicals. Advocacy as it relates to the Government of Canada potential responses to the US Administration Most Favored Nation drug pricing policy Monitoring and engaging on the Government’s national strategy for rare diseases; the Canadian Drug Agency; and the implementation of C64, An Act to Implement pharmacare. Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related new guidelines. Advocacy on the Regulations Amending the Patent Rules and Certain Regulations Made Under the Patent Act which were published for consultation in Canada Gazette Part I (CGI) on May 18, 2024.1 Share concerns with Canada’s implementation of a patent term adjustment (PTA) system that is not compliant with its trade obligations, as it does not provide a meaningful remedy to patentees who are impacted by unreasonable patent office delays. Advocacy related to the federal government consultation on the review of the Canada US Mexico Trade Agreement Advocacy on the role of the Health Emergency Readiness Canada (HERC) Agency Advocacy with respect to Canada's proposed Countermeasures in Response to United States Tariffs on Canadian goods The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability. Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Drug Agency as well as the review times and processes conducted by Health Canada for the purpose of obtaining a notice of compliance. Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's life sciences & biomanufacturing strategy Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries Engage the Federal Government on Health Canada’s Regulatory Innovation Agenda (Agile Licensing Modernization) to discuss opportunities for further harmonization; flexibility and predictability in the new regulatory framework being develop and its linkage to pillar 5 of the Biomanufacturing and Life Sciences Strategy. Discussions on the procurement of a COVID19 vaccine and therapy Discussions around the World Trade Organization consideration of a TRIPS Patent Waiver and the World Health Organization pandemic treaty proposal Consider amendments to the Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of potential importation legislation in the United States. Advocacy to maintain and increase funding for the National Immunization Strategy and discussions on vaccine procurement.

Fisheries Act - Section 35 in respect of compliance for projects near water in the mineral industry Metal and Diamond Mining Effluent Regulations (MDMER) respecting Export and Import of Hazardous Wastes as it relates to mining and economic development Yukon, Northwest Territories and Nunavut Mining Regulations in respect of Mineral Tenure management in the Yukon, NWT and Nunavut. Yukon, Northwest Territories and Nunavut Mining Regulations in respect of amendments to the administration of prospecting permits and mineral claims Workplace Hazardous Materials Information System (WHMIS) as it relates to substances produced or used by the mining industry United Nations Declaration on Rights of Indigenous Peoples Act as it relates to mining sector activities UN Declaration on the Rights of Indigenous Peoples Act Action Plan in relation to providing input on the implementation of measures that intersect with mining activities Transportation of Dangerous Goods Act in regards to mining The Income Tax Act in relation to corporation taxation and the use of fiscal policy with regard to the mineral industry. Species at Risk Act as it relates to mining sector activities Safety of Life as Sea Convention at the International Maritime Organization Recommended Nunavut Land Use Plan in relation to land use implications for the mining sector of Nunavut Policies or programs at Infrastructure Canada, Transport Canada. CANNOR and other departments and agencies that pertain to trade-enabling infrastructure investment in remote and norther regions. Policies or programs at Environment and Climate Change Canada that relate to biodiversity conservation, including the development of the National Biodiversity Strategy Policies and programs that relate to energy renewal, energy efficiency and management, energy technology, clean technology and innovation. Oceans Act in respect to Marine protected areas Nunavut Planning and Project Assessment Act as it relates to mining sector activities Northwest Territories and Nunavut Mining Regulations in respect of royalty administration and diamond valuation, as applicable. Northern Northwest Territories and Nunavut Mining Regulations in respect of Mineral Tenure management in the NWT and Nunavut. Nature Accountability Legislation (anticipated in 2024) National Benefits Sharing Framework in relation to providing input on the design and implementation of the framework Migratory Birds Regulations as it relates to mining sector activities Migratory Birds Convention Act as it relates to mining sector activities MacKenzie Valley Resource Management Boards and Agencies in respect of effluent regulations for diamond mining in Canada Mackenzie Valley Land and Water Boards, Mackenzie Valley Environmental Impact Review Board, Yukon Environment and Socio-economic Assessment Board, Yukon Water Board, Nunavut Impact Review Board, Nunavut Water Board as they relate to (published or unpublished) reasons for decisions made in environmental assessment and permitting; appointments with respect to relevant qualifications and professional and technical experience of Board appointees, and policy decision that affect effluent standards set in water permits. Impact Assessment Act & Regs. as they affect assessment of projects in the mineral industry Human Resources - Human Resources Development Canada - Mining skills development and training programs for Indigenous and under-represented groups in mining (female, new Canadians), with the Mining Industry Human Resources Council (MIHR) Formerly Bill C-17 - Amendments to the Yukon Environmental and Socio-economic Assessment Act (YESSA) and subsequent engagement on related issues as it pertains to the mining industry. Foreign investment and trade as it relates to Foreign Investment Agreements (FIPAs) and Free Trade Agreements (FTAs) Fisheries Act in respect of the Metal and Diamond Mining Effluent Regulations (MDMER), the proposed Coal Mining Effluent Regulations (CMER) and proposed regulations for